JP2017530185A5 - - Google Patents

Download PDF

Info

Publication number
JP2017530185A5
JP2017530185A5 JP2017518989A JP2017518989A JP2017530185A5 JP 2017530185 A5 JP2017530185 A5 JP 2017530185A5 JP 2017518989 A JP2017518989 A JP 2017518989A JP 2017518989 A JP2017518989 A JP 2017518989A JP 2017530185 A5 JP2017530185 A5 JP 2017530185A5
Authority
JP
Japan
Prior art keywords
methyl
dichlorophenyl
dihydroisoquinolin
ethanone
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017518989A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017530185A (ja
JP6622299B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/073053 external-priority patent/WO2016055479A1/en
Publication of JP2017530185A publication Critical patent/JP2017530185A/ja
Publication of JP2017530185A5 publication Critical patent/JP2017530185A5/ja
Application granted granted Critical
Publication of JP6622299B2 publication Critical patent/JP6622299B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017518989A 2014-10-08 2015-10-06 テトラヒドロイソキノリン誘導体 Active JP6622299B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14188174.8 2014-10-08
EP14188174 2014-10-08
PCT/EP2015/073053 WO2016055479A1 (en) 2014-10-08 2015-10-06 Tetrahydroisoquinoline derivatives

Publications (3)

Publication Number Publication Date
JP2017530185A JP2017530185A (ja) 2017-10-12
JP2017530185A5 true JP2017530185A5 (enExample) 2019-10-03
JP6622299B2 JP6622299B2 (ja) 2019-12-18

Family

ID=51790569

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017518989A Active JP6622299B2 (ja) 2014-10-08 2015-10-06 テトラヒドロイソキノリン誘導体

Country Status (18)

Country Link
US (1) US10105359B2 (enExample)
EP (1) EP3204359B1 (enExample)
JP (1) JP6622299B2 (enExample)
CN (1) CN107001278B (enExample)
BR (1) BR112017007123B1 (enExample)
CA (1) CA2963951C (enExample)
CY (1) CY1123417T1 (enExample)
DK (1) DK3204359T3 (enExample)
EA (1) EA035544B1 (enExample)
ES (1) ES2821821T3 (enExample)
HR (1) HRP20201469T1 (enExample)
HU (1) HUE050664T2 (enExample)
LT (1) LT3204359T (enExample)
PL (1) PL3204359T3 (enExample)
PT (1) PT3204359T (enExample)
RS (1) RS60933B1 (enExample)
SI (1) SI3204359T1 (enExample)
WO (1) WO2016055479A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017222958B2 (en) * 2016-02-25 2019-07-18 Asceneuron S. A. Glycosidase inhibitors
CN108884050B (zh) * 2016-04-13 2022-07-05 Ucb生物制药私人有限公司 四氢异喹啉衍生物
CN107698433A (zh) * 2017-09-12 2018-02-16 潍坊滨海石油化工有限公司 苯乙酸的制备方法
EA202091323A1 (ru) 2017-12-01 2020-10-09 Юсб Байофарма Срл Визуализирующие средства
TWI725408B (zh) * 2018-04-20 2021-04-21 美商美國禮來大藥廠 多巴胺d1受體正向異位調節劑
IL289317B2 (en) * 2019-07-01 2025-09-01 UCB Biopharma SRL Tetrahydroisoquinoline derivative is transformed as a positive allosteric modulator d1
PH12021552825A1 (en) * 2019-07-01 2022-10-03 UCB Biopharma SRL A substituted tetrahydroisoquinoline derivative as a d1 positive allosteric modulator
KR20230014706A (ko) * 2020-04-24 2023-01-30 더 리전츠 오브 더 유니버시티 오브 캘리포니아 Nurr1 수용체 조절제 및 이의 용도
CN111943930B (zh) * 2020-08-25 2022-11-01 南京三元阳普医药科技有限公司 Lasmiditan的合成工艺
ES2976784T3 (es) * 2020-10-07 2024-08-08 Lilly Co Eli Derivados de fenil-3,4-dihidroisoquinolin-2(1H)-il-etan-1-ona como moduladores alostéricos positivos del receptor de dopamina D1
CA3198635A1 (en) * 2020-12-03 2022-06-09 UCB Biopharma SRL Octahydroisoquinolinyl derivatives
JP7798891B2 (ja) * 2020-12-18 2026-01-14 ユーシービー バイオファルマ エスアールエル D1陽性アロステリック調節因子としての置換テトラヒドロイソキノリン誘導体
US20240083925A1 (en) * 2020-12-18 2024-03-14 UCB Biopharma SRL Prodrugs of 2-(3,5-Dichloro-1-methyl-indazol-4-yl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone
ES3000719T3 (en) 2020-12-18 2025-03-03 UCB Biopharma SRL Dihydroisoquinolinyl derivatives
WO2022129267A1 (en) * 2020-12-18 2022-06-23 UCB Biopharma SRL Amorphous solid dispersions
CN117377470A (zh) 2021-03-08 2024-01-09 伊莱利利公司 美维达林和其他d1正向别构调节剂在幻觉和痴呆相关精神病的治疗中的用途
EP4304577A1 (en) 2021-03-09 2024-01-17 Eli Lilly And Co. Use of mevidalen and other d1 positive allosteric modulators for slowing of parkinson's disease progression
CN114671810B (zh) * 2022-03-21 2024-03-22 济南鸿湾生物技术有限公司 一种咪唑苯脲的制备方法
CN115611768B (zh) * 2022-11-14 2024-03-05 郑州大学 一种3,4-二氯苯腈的合成方法
CN118724764B (zh) * 2024-06-07 2025-11-18 绍兴文理学院 一种芳基伯磺酰胺类化合物的制备方法
CN119569653B (zh) * 2024-11-25 2026-04-14 滁州市庆云医药有限公司 一种罗沙司他中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766131A (en) * 1980-10-17 1988-08-23 Pennwalt Corporation 2-amino (or hydroxy) phenethyl-1,2,3,4-tetrahydroisoquinolines as analgesics
MXPA04005988A (es) 2001-12-19 2004-09-27 Lundbeck & Co As H 3,4-dihidro-1h-isoquinolin-2-il-derivados.
WO2005111025A1 (en) * 2004-04-29 2005-11-24 Aventis Pharmaceuticals Inc. 3-piperidinylisochroman-5-ols as dopamine agonists
CA2679735A1 (en) * 2007-03-01 2008-09-12 Janssen Pharmaceutica N.V. Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor

Similar Documents

Publication Publication Date Title
JP2017530185A5 (enExample)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2016517878A5 (enExample)
RU2606497C2 (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
ES2629414T3 (es) Derivados de tiazol
JP2021500345A5 (enExample)
JP2020506946A5 (enExample)
RU2018140092A (ru) Новые пиразолпиримидиновые производные
RU2018123779A (ru) Новые соединения
HRP20210143T1 (hr) 2-heteroaril-3-okso-2,3-dihidropiridazin-4-karboksamidi za liječenje raka
JP2014506599A5 (enExample)
JP2010510319A5 (enExample)
JP2016523911A5 (enExample)
JP2017503837A5 (enExample)
JP2016513660A5 (enExample)
JP2017511794A5 (enExample)
JP2019513776A5 (enExample)
HRP20130106T1 (hr) Imidazotriazini i imidazopirimidini kao inhibitori kinaze
JP2014526549A5 (enExample)
JP2019504009A5 (enExample)
JP2019508384A (ja) 5−置換2−(モルホリン−4−イル)−1,7−ナフチリジン
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
HRP20171670T1 (hr) Spojevi i sastavi za moduliranje egfr-aktiviteta
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
JP2015523390A (ja) 置換型ピラゾロン化合物及び使用方法